| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CHECK CAP LTD | 15,250 | 10,000 | 0.01% | ||
| 2 | BioPharmX Corporation | 77,031 | 29,000 | 0.03% | ||
| 3 | GENVEC INC | 9,580 | 31,000 | 0.03% | ||
| 4 | AVINGER INC | 25,000 | 93,000 | 0.08% | ||
| 5 | SYNERGY PHARMACEUTICALS DEL | 34,000 | 207,000 | 0.18% | ||
| 6 | Spring Bank Pharmaceuticals In | 27,412 | 219,000 | 0.19% | ||
| 7 | CELYAD SA | 12,528 | 222,000 | 0.20% | ||
| 8 | NEOS THERAPEUTICS INC COM | 38,873 | 227,000 | 0.20% | ||
| 9 | ESSA Pharma | 98,046 | 289,000 | 0.25% | ||
| 10 | Pieris Pharmaceuticals | 223,325 | 314,000 | 0.28% | ||
| 11 | ABEONA THERAPEUTICS INC | 76,800 | 372,000 | 0.33% | ||
| 12 | BIOCRYST PHARMACEUTICALS | 65,900 | 417,000 | 0.37% | ||
| 13 | EIGER BIOPHARMACEUTICALS INC | 40,192 | 468,000 | 0.41% | ||
| 14 | SCYNEXIS INC | 173,645 | 554,000 | 0.49% | ||
| 15 | BLUEBIRD BIO INC COM | 9,000 | 555,000 | 0.49% | ||
| 16 | ARBUTUS BIOPHARMA CORP | 234,000 | 573,000 | 0.50% | ||
| 17 | INOTEK PHARMACEUTICALS CORP | 600,000 | 618,000 | 0.54% | PRN | |
| 18 | MASIMO CORP | 10,000 | 674,000 | 0.59% | ||
| 19 | CONCERT PHARMACEUTICALS INCORPORATED | 66,968 | 689,000 | 0.61% | ||
| 20 | IRONWOOD PHARMACEUTICALS INC DBCV 2.250 6/1 | 600,000 | 690,000 | 0.61% | PRN | |
| 21 | COGENTIX MED INC | 353,482 | 710,000 | 0.62% | ||
| 22 | NOVADAQ TECHNOLOGIES INC | 101,841 | 722,000 | 0.63% | ||
| 23 | SYNERON MEDICAL LTD | 85,947 | 722,000 | 0.63% | ||
| 24 | ACHILLION PHARMACEUTICALS IN | 196,500 | 812,000 | 0.71% | ||
| 25 | NEURODERM LTD | 37,921 | 842,000 | 0.74% | ||
| 26 | ArQule Inc | 668,735 | 843,000 | 0.74% | ||
| 27 | Exactech Inc | 31,636 | 864,000 | 0.76% | ||
| 28 | Stereotaxis Inc | 1,372,862 | 892,000 | 0.78% | ||
| 29 | ZOGENIX INC | 74,538 | 906,000 | 0.80% | ||
| 30 | Protagonist Therapeutics, Inc. | 45,586 | 1,002,000 | 0.88% | ||
| 31 | Ascendis Pharma | 53,000 | 1,073,000 | 0.94% | ||
| 32 | JOHNSON & JOHNSON | 9,400 | 1,083,000 | 0.95% | ||
| 33 | UNIQURE NV | 203,907 | 1,142,000 | 1.00% | ||
| 34 | ADVAXIS INC COM NEW | 175,000 | 1,253,000 | 1.10% | ||
| 35 | INOTEK PHARMACEUTICALS CORP | 237,135 | 1,447,000 | 1.27% | ||
| 36 | AEGLEA BIOTHERAPEUTICS INC | 350,392 | 1,524,000 | 1.34% | ||
| 37 | PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | 1,546,000 | 1.36% | PRN | |
| 38 | TANDEM DIABETES CARE INC COM | 724,286 | 1,557,000 | 1.37% | ||
| 39 | SPECTRANETICS CORP | 65,496 | 1,605,000 | 1.41% | ||
| 40 | CIDARA THERAPEUTICS INC | 159,918 | 1,663,000 | 1.46% | ||
| 41 | BioTelemetry Inc | 75,000 | 1,676,000 | 1.47% | ||
| 42 | MACROGENICS INC | 89,200 | 1,823,000 | 1.60% | ||
| 43 | DERMA SCIENCES ORD | 353,718 | 1,839,000 | 1.62% | ||
| 44 | CARA THERAPEUTICS INC | 209,522 | 1,946,000 | 1.71% | ||
| 45 | BLUEPRINT MEDICINES CORP COM | 72,500 | 2,034,000 | 1.79% | ||
| 46 | RADIUS HEALTH INCORPORATED COM NEW | 53,854 | 2,048,000 | 1.80% | ||
| 47 | IMMUNOMEDICS INCORPORATED | 559,674 | 2,054,000 | 1.80% | ||
| 48 | TESARO INCORPORATED | 15,500 | 2,084,000 | 1.83% | ||
| 49 | ISHARES TR | 8,700 | 2,309,000 | 2.03% | ||
| 50 | INSULET CORP 2 06/15/2019 | 2,250,000 | 2,457,000 | 2.16% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-17-000014, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
